The relations between metabolic surgery and diabetic remission
Main Article Content
Abstract
Objective: To analyze the effects of bariatric surgery on diabetic remission. Bibliographic review: Bariatric surgery is used to reduce the body weight generated by obesity, so it relates to the improvement of metabolic syndrome. Therefore, when such a procedure aims to attenuate the symptoms of such a pathology, metabolic surgery is named, after all, this is capable of causing the remission of type 2 diabetes, which is a chronic metabolic disease characterized by peripheral insulin resistance. Moreover, the main technique used is Roux-en-Y anastomosis gastric bypass, because it has lower mortality rates and for generating more satisfactory results compared to drug treatments. Furthermore, a decrease in triglycerides and LDL causes obvious benefits, such as a decrease in cardiovascular risks, for example, blood pressure and abdominal waist. On the other hand, there is a deficiency in the absorption of iron, vitamins and minerals after surgery. Final considerations: Delsarte, this surgical procedure is a significantly beneficial alternative for diabetic remission, improvement of self-esteem and quality of life.
Article Details
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
References
2. ALVES M, et al. Cirurgia metabólica/bariátrica para pacientes com diabetes tipo 2, terapia convencional, intervenções cirúrgicas, técnicas utilizadas, alterações hormonais e alimentares após o procedimento: uma revisão integrativa. Health Residencies Journal, 2022; 3(1): 453–471.
3. ALVES M, et al., Orientação nutricional e da terapêutica farmacológica da diabetes após cirurgia bariátrica. Rev Port Endocrinol Diabetes Metab, 2019; 14(1): 58-67.
4. ARTERBURN DE, et al. Benefits and risks of bariatric surgery in adults: a review. Jama, 2020; 324(9): 879-887.
5. CAMARGOS AR, et al. A eficácia das técnicas da cirurgia bariátrica na remissão da diabetes mellitus tipo 2. Revista Eletrônica Acervo Científico, 2021; 26: e7541.
6. CAMPOS J, et al. The Role Of Metabolic Surgery For Patients With Obesity Grade I And Type 2 Diabetes Not Controlled Clinically. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 2016; 29(1): 102–06.
7. CASTANHA CR, et al. Avaliação da qualidade de vida, perda de peso e comorbidades de pacientes submetidos à cirurgia bariátrica. Revista do Colégio Brasileiro de Cirurgiões, 2018; 45(3).
8. CFM. Resolução nº 2.172/2017. Resoluções. Brasília, 2017. Disponível em: https://sistemas.cfm.org.br. Acessado em: 14 de dezembro de 2022.
9. DAMASO CA, et al. A preeminência da cirurgia metabólica como tratamento para diabetes tipo 2. Brazilian Journal of Health Review, 2021; 4(5): 22048-22054.
10. DING L, et al. Comparative effectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials. Obesity Reviews, 2020; 21(8): e13030.
11. DOS SANTOS CA. Associação no longo-termo entre a prática de atividade física, o reganho de peso, fatores de risco metabólico e qualidade de vida, em pacientes submetidos a cirurgia bariátrica: Revisão Sistemática da Literatura. Retos: nuevas tendencias en educación física, deporte y recreación, 2022; 46(1): 622-630.
12. FUCHS T, et al. The sleeve gastrectomy and the management of type 2 diabetes. Arquivos Brasileiros de Cirurgia Digestiva: ABCD = Brazilian Archives of Digestive Surgery, 2017; 30(4): 283–86.
13. KOLIAKI C, et al. The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC endocrine disorders, 2017; 17(1).
14. MACHADO AB, et al. Remissão do diabetes mellitus tipo 2 em pacientes submetidos à cirurgia bariátrica: revisão integrativa da literatura. Brazilian Journal of Development, 2021; 7(10): 99120–99129.
15. MAGALHÃES BF, et al. O uso da cirurgia bariátrica no controle do diabetes tipo 2 em pacientes com índice de massa corpórea ≤35 kg/m2. Revista Eletrônica Acervo Saúde, 2019; 35(1): e1719.
16. MARCHETTI G. The effect of Roux-en-Y gastric bypass in the treatment of hypertension and diabetes. Revista do Colégio Brasileiro de Cirurgiões, 2020; 47(1): e20202655.
17. NORONHA CG, et al. Modelo metabonômico para avaliação da regressão do diabetes mellitus tipo 2 após cirurgia bariátrica. Revista do Colégio Brasileiro de Cirurgiões, 2020; 47(1): e20202394.
18. NUNES JS, et al. Consenso Nacional para o Tratamento Cirúrgico da Diabetes Tipo 2. Revista Portuguesa de Diabetes, 2018; 13(2): 78-86.
19. PAREEK M, et al. Metabolic surgery: weight loss, diabetes, and beyond. Journal of the American College of Cardiology, 2018; 71(6): 670-687.
20. PARUSSOLO GS, et al. Manejo da obesidade: uma revisão narrativa dos tratamentos com foco na cirurgia metabólica. Research, Society and Development, 2022; 11(3): e13711326129–e13711326129.
21. RIDDLE MC, et al. Consensus Report: Definition and interpretation of remission in type 2 diabetes. J Clin Endocrinol Metab., 2022; 107(1): 1-9.
22. SANTOS MMM, et al. Avaliação da condição de saúde e da qualidade de vida no pós-operatório tardio de pacientes submetidos à cirurgia bariátrica. RBONE-Revista Brasileira de Obesidade, Nutrição e Emagrecimento, 2018; 12(74): 730-737.
23. SHENG B, et al. The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: A systematic review and meta-analysis. Obesity Surgery, 2017; 27(1): 2724–2732.
24. SOUZA LF e SANTOS EVL. Remissão da diabetes mellitus tipo II em pacientes submetidos à cirurgia bariátrica. Revista Brasileira de Educação e Saúde, 2021; 11(2): 152–58.
25. TSILINGIRIS D, et al. Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: Fact or Fiction? International Journal of Environmental Research and Public Health, 2019; 16(17): 3171.